No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
District Court Finds Regeneron Eylea® (aflibercept) Formulation Patent Valid and Infringed by Mylan, but Infringed MOT Patent Claims Invalid
Judge Thomas Kleeh of the US District Court for the Northern District of West Virginia has found that Mylan infringed or induced infringement of three Regeneron Eylea® (aflibercept) patents. The Court published a short form judgment and concluded that: Mylan...